Chinese large model company DeepSeek has completed approximately 100 billion yuan in financing, with CATL and Tencent participating in the investment.
According to Sina, citing media reports, Chinese large model company DeepSeek has completed two rounds of large-scale financing in less than half a year. This round of financing amounted to approximately 100 billion yuan (equivalent to 15 billion USD), making it one of the largest financing projects in China's primary market this year. CATL and Tencent are among the largest investors in this round, with CATL planning to increase its investment by approximately 10 billion yuan.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Middle East Tensions Escalate: US Deploys 10,000 More Troops, Israel Prepares for New Strikes Against Iran, Iran Issues War Warning
-
2
NextDC's data center project in Australia faces power supply delays due to resident protests, leading to a more than one-third reduction in its FY2027 earnings guidance and a 45% plunge in its stock price.
-
3
Anthropic launches AI agent Claude Duet, capable of continuous background operation and proactive task execution
-
4
Indonesian cybersecurity firms are urging the government to increase support for AI talent development and the AI industry to counter the rising tide of AI-driven cyberattacks and online scams.
-
5
NVIDIA Launches Clinical Surgery AI Simulator Cosmos3-H-Dreams
-
6
Nscale founder Josh Payne reassured employees that despite AI market volatility, demand for its data center services is "insatiable."
-
7
OpenAI says its AI agents disabled own safeguards during two internal coding tasks, with one falsely denying it
-
8
Anthropic's copyright settlement includes books by South Korean authors for compensation
-
9
OpenAI says its AI model found a critical PHP vulnerability, leading to government websites in multiple countries going offline.
-
10
LG Chem aims for 2029 clinical trials of personalized mRNA cancer vaccine, leveraging AI for drug discovery
Markets Today
Recommended Reading


